< Back to previous page
Researcher
Robert Snoeck
- Disciplines:Microbiology, Systems biology, Laboratory medicine
Affiliations
- Laboratory of Virology and Chemotherapy (Rega Institute) (Division)
Member
From1 Oct 1999 → Today
Projects
1 - 10 of 15
- Viral Oncology: molecular biology and pathogenesis of post-transplant lymphoproliferative disorder (PTLD)From13 Sep 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Dynamics of cytomegalovirus infection: evolution towards antiviral drug resistanceFrom1 Feb 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Intravital microscopy platform for infectious and inflammatory diseasesFrom1 May 2020 → TodayFunding: FWO Medium Size Research Infrastructure
- Challenges and opportunities in the management of herpes simplex virus antiviral resistanceFrom17 Apr 2018 → 17 Apr 2022Funding: Own budget, for example: patrimony, inscription fees, gifts
- Unravelling the role of BK polyomavirus genetic variants in viral pathogenicity and clearance in kidney transplant recipientsFrom1 Apr 2018 → 8 Mar 2024Funding: Own budget, for example: patrimony, inscription fees, gifts
- Challenges and opportunities in the management of herpesvirus antiviral-resistanceFrom1 Jan 2018 → 31 Dec 2021Funding: FWO research project (including WEAVE projects)
- Unraveling the role of BK polyomavirus variants and of cellular CMP kinase on viral pathogenicity and clearance in renal-transplant patientsFrom1 Oct 2017 → 30 Sep 2021Funding: FWO Applied Biomedical Research (TBM)
- Automated real-time quantitative live cell analysisFrom1 Oct 2016 → 30 Sep 2018Funding: Fund Recuperation Fiscal Exemption
- The role of Tumor Micro-Environment in the pathogenesis and prognosis of EBV lymphomas: a study in human tumor biopsies and an novel Patient Derived Tumor Xenograft mouse modelFrom1 Sep 2016 → 25 Nov 2020Funding: Private funding of national origin - undefined
- MERKEL CELL CARCINOMA, TOWARDS THE IDENTIFICATION OF NOVEL MOLECULAR TARGETS AND THE ESTABLISHMENT OF A THREE-DIMENSIONAL CELL CULTURE MODELFrom9 Nov 2015 → 14 Dec 2020Funding: Own budget, for example: patrimony, inscription fees, gifts
Publications
41 - 50 of 236
- Viral fitness of MHV-68 viruses harboring drug resistance mutations in the protein kinase or thymidine kinase(2020)
Authors: Erika Trompet, Dimitrios Topalis, Robert Snoeck, Graciela Andrei
- New acetamide derivatives containing (omega-p-bromophenoxyalkyl)uracil moiety and their anticytomegalovirus activity(2020)
Authors: Robert Snoeck, Graciela Andrei
Pages: 602 - 603 - Design, synthesis, chemical characterization, biological evaluation, and docking study of new 1,3,4-oxadiazole homonucleoside analogs(2020)
Authors: Robert Snoeck, Graciela Andrei
Pages: 1088 - 1107 - Uracil-Containing Heterodimers of a New Type: Synthesis and Study of Their Anti-Viral Properties(2020)
Authors: Robert Snoeck, Graciela Andrei
- BKTyper: Free Online Tool for Polyoma BK Virus VP1 and NCCR Typing(2020)
Authors: Olga Mineeva-Sangwo, Dimitrios Topalis, Robert Snoeck, Graciela Andrei, Piet Maes
- Amidate Prodrugs of O-2-Alkylated Pyrimidine Acyclic Nucleosides Display Potent Anti-Herpesvirus Activity(2020)
Authors: Elisabetta Groaz, Robert Snoeck, Graciela Andrei, Piet Herdewyn
Pages: 1410 - 1415 - Synthesis and Antiviral Properties of 1-Substituted 3-[(omega-(4-Oxoquinazolin-4(3H)-yl)alkyl]uracil Derivatives(2020)
Authors: Robert Snoeck, Graciela Andrei
Pages: 134 - 139 - Substituted adamantylphthalimides: Synthesis, antiviral and antiproliferative activity(2020)
Authors: Robert Snoeck, Graciela Andrei
- Design, synthesis and antiviral evaluation of novel acyclic phosphonate nucleotide analogs with triazolo[4,5-b]pyridine, imidazo[4,5-b]pyridine and imidazo[4,5-b]pyridin-2(3H)-one systems(2020)
Authors: Dominique Schols, Graciela Andrei, Robert Snoeck
Pages: 542 - 591 - Antitumor and antiviral activities of 4-substituted 1,2,3-triazolyl-2,3-dibenzyl-L-ascorbic acid derivatives(2019)
Authors: Dominique Schols, Robert Snoeck, Graciela Andrei
Patents
1 - 6 of 6
- Prodrugs of nucleoside phosphonates (Inventor)
- Novel prodrugs of nucleoside phosphonates (Inventor)
- Novel purine derivatives and drugs comprising same (Inventor)
- Prodrugs of fluorinated acyclic nucleoside phosphonates (Inventor)
- Prodrugs of fluorinated acyclic nucleoside phosphonates (Inventor)
- Novel prodrugs of nucleoside phosphonates (Inventor)